These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25786523)

  • 21. Effects of phenobarbital and 3-methylcholanthrene pretreatment on size, sedimentation velocity, and mixed function oxygenase activity of rat hepatocytes.
    Sweeney GD; Jones KG; Krestynski F
    J Lab Clin Med; 1978 Mar; 91(3):444-54. PubMed ID: 415100
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Maintenance of in vivo induced cytochrome P-450s in hepatocyte monolayers at non freezing temperatures.
    Evans PJ
    Cryobiology; 2015 Apr; 70(2):204-7. PubMed ID: 25666303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Fenofibrate prevents orotic acid--induced hepatic steatosis in rats.
    Ferreira AV; Parreira GG; Porto LC; Mario EG; Delpuerto HL; Martins AS; Botion LM
    Life Sci; 2008 Apr; 82(15-16):876-83. PubMed ID: 18374364
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Modulation of 3-methylcholanthrene-induced rat hepatic and renal cytochrome P450 and phase II enzymes by plant phenols: protocatechuic and tannic acids.
    Krajka-Kuźniak V; Szaefer H; Baer-Dubowska W
    Toxicol Lett; 2004 Sep; 152(2):117-26. PubMed ID: 15302093
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of inducers on hepatic microsomal mixed function oxidase system of male rats during food restriction.
    Ahmed RS; Pawar SS
    Indian J Exp Biol; 1997 Jan; 35(1):46-9. PubMed ID: 9279133
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Biochemical and immunohistochemical analysis of orotic acid-induced fatty liver.
    Murakoshi M; Suemizu H; Takekoshi S; Misawa M; Watanabe K
    Tokai J Exp Clin Med; 1991 Oct; 16(3-4):197-201. PubMed ID: 1811353
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Immunohistochemical localization of cytochrome P-450a in liver sections from untreated rats and rats treated with phenobarbital or 3-methylcholanthrene.
    Moody DE; Taylor LA; Smuckler EA; Levin W; Thomas PE
    Drug Metab Dispos; 1983; 11(4):339-43. PubMed ID: 6137340
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Oltipraz-mediated changes in aflatoxin B(1) biotransformation in rat liver: implications for human chemointervention.
    Buetler TM; Bammler TK; Hayes JD; Eaton DL
    Cancer Res; 1996 May; 56(10):2306-13. PubMed ID: 8625305
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Study on possible mechanism of orotic acid-induced fatty liver in rats.
    Wang YM; Hu XQ; Xue Y; Li ZJ; Yanagita T; Xue CH
    Nutrition; 2011 May; 27(5):571-5. PubMed ID: 21167679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A polyphenol extract modifies quantity but not quality of liver fatty acid content in high-fat-high-sucrose diet-fed rats: possible implication of the sirtuin pathway.
    Aoun M; Michel F; Fouret G; Casas F; Jullien M; Wrutniak-Cabello C; Ramos J; Cristol JP; Coudray C; Carbonneau MA; Feillet-Coudray C
    Br J Nutr; 2010 Dec; 104(12):1760-70. PubMed ID: 20673376
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combined effects of garlic oil and fish oil on the hepatic antioxidant and drug-metabolizing enzymes of rats.
    Chen HW; Tsai CW; Yang JJ; Liu CT; Kuo WW; Lii CK
    Br J Nutr; 2003 Feb; 89(2):189-200. PubMed ID: 12575903
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Therapeutic role of niacin in the prevention and regression of hepatic steatosis in rat model of nonalcoholic fatty liver disease.
    Ganji SH; Kukes GD; Lambrecht N; Kashyap ML; Kamanna VS
    Am J Physiol Gastrointest Liver Physiol; 2014 Feb; 306(4):G320-7. PubMed ID: 24356885
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dietary orotic acid accentuates the hepatic response to phenobarbital in rats.
    Haines DS; Wu M; Tokmakjian SD
    Biochem Cell Biol; 1990 Sep; 68(9):1146-9. PubMed ID: 1701644
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of Fatty Liver Induced by Excess Orotic Acid on B-Group Vitamin Concentrations of Liver, Blood, and Urine in Rats.
    Shibata K; Morita N; Kawamura T; Tsuji A; Fukuwatari T
    J Nutr Sci Vitaminol (Tokyo); 2015; 61(5):355-61. PubMed ID: 26639842
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dehydroepiandrosterone sulfate increases hepatic ubiquinone-9 in male F-344 rats.
    Khan SA
    Pharmazie; 2004 Jun; 59(6):491-2. PubMed ID: 15248468
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Feed-drug interaction of orally applied butyrate and phenobarbital on hepatic cytochrome P450 activity in chickens.
    Mátis G; Kulcsár A; Petrilla J; Hermándy-Berencz K; Neogrády Z
    J Anim Physiol Anim Nutr (Berl); 2016 Aug; 100(4):637-42. PubMed ID: 26614344
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Sex difference in the development of fatty liver by orotic acid.
    Negishi I; Aizawa Y
    Jpn J Pharmacol; 1975 Jun; 25(3):289-94. PubMed ID: 171467
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Fatty liver of growing rats fed excess lysine and its prevention by adenine or allopurinol.
    Ulman EA; Ifft KH; Kari FW; Visek WJ
    Lipids; 1981 May; 16(5):393-6. PubMed ID: 6789027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fatty livers induction by orotic acid contained in skim milk powder.
    Okonkwo PO; Kinsella JE
    Experientia; 1974 Sep; 30(9):993-4. PubMed ID: 4413448
    [No Abstract]   [Full Text] [Related]  

  • 40. Specific binding of dehydroepiandrosterone sulfate to rat liver cytosol: a possible association with peroxisomal enzyme induction.
    Yamada J; Sugiyama H; Sakuma M; Suga T
    Biochim Biophys Acta; 1994 Oct; 1224(1):139-46. PubMed ID: 7999152
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.